A genetic diagnosis may guide therapeutic changes (Supplemental Table 1) such as switch from insulin to sulfonylureas (SU) in patients with NDM due to KCNJ11 or ABCC8 (ATP-sensitive potassium channel genes, KATP) variants [8, 9]. This evidence concerns the gene ABCC8 and neonatal diabetes mellitus.